RECRUITING Not applicable ClinicalTrials.gov

Mobile Technology to Reduce Teen Substance Misuse

Sponsor: Evidence-Based Practice Institute, Seattle, WA • ClinicalTrials.gov ID: NCT05897164

Registry updated: 2026-08-20

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Description

The goal of this study is to test the newly expanded WisePath for Teens (WPT) for substance use app, a direct-to-consumer paired mobile phone app for iOS and Android platforms that supports parents/guardians in delivering evidence-based techniques to reduce youth substance abuse and co-occurring mental health problems. This project will expand WPT for use with a general population of teens with problematic substance use and their parents to reduce substance abuse, its harmful effects, opioid overdoses, and progression to substance use disorders, as well as other behavioral health problems that are exacerbated by substance abuse and/or interfere with substance abuse treatment.

Interventions

WisePath for Teens (Other)
WPT is a paired mobile phone app for use on both Android and iOS operating systems by youth experiencing SA and their parents/guardians.
Peer Support Services (PSS) (Behavioral)
PSS are provided by people with lived experience with histories of adolescent substance abuse and are now in recovery who are also certified as peer support specialists. A specialist will virtually (e.g., over the phone, screensharing) meet with families regularly to provide support and ensure that families are able to use iKinnect-SA and access the app's features.
Control (Device)
Website with icon on participant's phone with Android or iOS operating systems.

Eligibility criteria

INCLUSION CRITERIA: Youth: * Resides in United States * 13-17 years of age * Fluent in English * Possesses and is the primary user of an Android or iPhone-based smartphone with a data plan that they use on a daily basis * Currently residing in the same household with the linked caregiver/legal guardian participant at least five days a week * Meets criteria for mild-moderate or severe SA (for any drug or alcohol) on the Screening to Brief Intervention (S2BI), indicated by answering that they have used any substance at least once per month within the past 90 days. * Possesses and is the primary user of an Android or iPhone-based smartphone with a data plan Caregivers: * Resides in United States * 18 years or older * Fluent in English * Owns and is the primary user of an Android or iPhone-based smartphone with a data plan that they use on a daily basis * Able and willing to receive and send several (1-3 times/week) text messages from study staff during study participation * Is the primary caregiver of a youth aged 13-17 years who lives in the caregiver's home at least five days a week * Caregiver indicates a substance concern for the target youth, defined as either a+b OR c: 1. uses alcohol, marijuana, and/or another substance, AND 2. expresses that they are concerned (a score of 3 or higher) about that use on a 5-pt Likert scale (3 = concerned, 4 = very concerned, 5 = extremely concerned). OR 3. The target youth participated in counseling or another form of treatment (e.g., medication assisted treatment) because of a concern about alcohol, marijuana, or other substance use. EXCLUSION CRITERIA Youth: * Participated in previous iKinnect or WisePath for Teens research in the past 2 years Caregivers: * Participated in previous iKinnect or WisePath for Teens research in the past 2 years * Currently involved with the child protective service system due to a concern about child maltreatment (i.e., abuse or neglect).

Conditions

Substance Use Substance Abuse Suicide Adolescent

Locations

University of Maryland, Baltimore — Baltimore, Maryland, United States
Evidence-Based Practice Institute — Seattle, Washington, United States

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record

Accelerate Your Clinical Trial Recruitment